April 28, 2026, 7:17 AM EDT. Zai Lab (ZLAB) shares have seen mixed movements, dropping 3.9% in a day but gaining 21.6% over the past month. Despite long-term shareholder returns remaining negative, recent momentum has risen. The stock trades at $21.88, significantly below an analyst fair value estimate of $49.49, suggesting it may be undervalued. Analysts recently lowered price targets, citing conservative revenue and margin assumptions alongside the stock's removal from a key conviction list. The company faces both positive fundamentals and execution risks such as commercialization challenges and pricing pressures in China. Investors are advised to evaluate Zai Lab's growth prospects, profitability outlook, and valuation gap closely before making decisions.